CVS HEALTH REPORTS THIRD QUARTER RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
'Several De-Risking Events Positive' for CVS Health (CVS) - Mizuho
November 2, 2022 12:58 PM EDTMizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS) following Q3 results as several de-risking events are positive for the stock.
The analyst commented, "CVS announced 1) good Q3:22 earnings, 2) provided 2023 initial 2023 EPS guidance of -3.5%... More
CVS Health (CVS) Tops Q3 EPS by 9c, Beats on Revenue; Offers FY22 EPS Guidance
November 2, 2022 6:34 AM EDTCVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.09 better than the analyst estimate of $2.00. Revenue for the quarter came in at $81.16 billion versus the consensus estimate of $76.76 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.55-$8.65, versus the consensus of... More



